Cargando…

Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

Detalles Bibliográficos
Autores principales:	Afzal, Amber, Fiala, Mark A., Jacoby, Meagan A., Walter, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393730/ https://www.ncbi.nlm.nih.gov/pubmed/37042968 http://dx.doi.org/10.1182/bloodadvances.2023009818

Ejemplares similares

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001
por: Janssen, Luca L.G., et al.
Publicado: (2023)

M2 Polarization May Contribute to Formation of Granulomatous Dermatitis in Progression of Myelodysplastic Syndrome to Acute Myeloid Leukemia
por: Fang, Wei-Cheng, et al.
Publicado: (2023)

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia
por: Weeks, Lachelle D., et al.
Publicado: (2022)

Rapidly Progressing Myelodysplastic Syndrome Initially Presenting as Acute Leukemia
por: Parylo, Sara, et al.
Publicado: (2017)

Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
por: Lee, Jun-beom, et al.
Publicado: (2017)

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen
por: Ali, Alaa M., et al.
Publicado: (2017)

Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes
por: Guidugli, L, et al.
Publicado: (2017)

Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level
por: Chen, Jiahao, et al.
Publicado: (2018)

Correction: Rapidly Progressing Myelodysplastic Syndrome Initially Presenting as Acute Leukemia
por: Parylo, Sara, et al.
Publicado: (2017)

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia
por: Quang, Violaine Tran, et al.
Publicado: (2023)

Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
por: Yuan, Shu
Publicado: (2015)

Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome
por: Niscola, Pasquale, et al.
Publicado: (2013)

Gene mutation spectrum of patients with myelodysplastic syndrome and progression to acute myeloid leukemia
por: Liu, Ming, et al.
Publicado: (2021)

310 Mechanisms of progression of myelodysplastic syndrome to fatal secondary acute myeloid leukemia
por: Chang, Daniel, et al.
Publicado: (2023)

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2023)

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Kapoor, Sargam, et al.
Publicado: (2021)

DNMT3a mutations in high-risk myelodysplastic syndrome parallel those found in acute myeloid leukemia
por: Ewalt, M, et al.
Publicado: (2011)

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia
por: Bellusci, Lorenza, et al.
Publicado: (2022)

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment
por: Gangat, N, et al.
Publicado: (2016)

Myelodysplastic Syndrome in Hemodialysis Patients
por: Ayari, Hamza, et al.
Publicado: (2019)

Attenuated Acceleration to Leukemia after Ezh2 Loss in Nup98-HoxD13 (NHD13) Myelodysplastic Syndrome
por: Ling, Victoria Y., et al.
Publicado: (2019)

The Relationship between Statins and Survival of Colorectal Cancer
por: Mohammadian, Mahdi, et al.
Publicado: (2023)

Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome
por: Guzzi, Nicola, et al.
Publicado: (2022)

Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
por: Qiao, Wei, et al.
Publicado: (2022)

Chronic lymphocytic leukemia followed by myelodysplastic syndrome and erythroleukemia
por: Cazaceanu, O, et al.
Publicado: (2012)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Targeted Sequencing Informs the Evaluation of Normal Karyotype Cytopenic Patients for Low-Grade Myelodysplastic Syndrome
por: Duncavage, Eric J., et al.
Publicado: (2016)

Elevated TWIST1 expression in myelodysplastic syndromes/ acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine
por: Li, Hongjiao, et al.
Publicado: (2020)

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
por: Komrokji, Rami S., et al.
Publicado: (2022)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
por: Huang, Huijun, et al.
Publicado: (2021)

A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats
por: Rodríguez, Sarai, et al.
Publicado: (2017)

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial
por: Kubasch, A. S., et al.
Publicado: (2023)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

The DAC system and associations with acute leukemias and myelodysplastic syndromes
por: Bug, Gesine, et al.
Publicado: (2010)

The Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome
por: McBride, Amanda, et al.
Publicado: (2019)

“Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”
por: Rasmussen, Bengt, et al.
Publicado: (2022)

When karyotype is decisive for myelodysplastic syndromes diagnosis
por: Perazzio, Aline dos Santos Borgo, et al.
Publicado: (2019)

Thoracic Purpura in a Patient with Myelodysplastic Syndrome
por: Gomes, Nuno, et al.
Publicado: (2021)

Statin use and survival among ESKD patients hospitalized with sepsis
por: Yu, Albert S, et al.
Publicado: (2021)

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
por: Platzbecker, U, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kbka8rvjsqoou7romdsjqc5f0p